Member Info for Tyke68

Paladin

I would say the FDA approvals (eg ODD etc), awards for imaging etc are not hype. They are factual, as will be the phase 1 results. If anything IBAI has not benefitted from the AI hype at all. Unlike some companies we actually have approved products on sale. The problem is sales/revenues. We are virtually at break even so sales are coming but not as fast as we hoped.

Thanks

Xviolet

Thank you, I got vilified recently when I mentioned the word “fun”. I hope the same doesn’t happen again. We all invest in our own different manners and make our own choices.

Good luck

Thanks

Xviolet

That’s what we all hope for but we all get frustrated waiting. The big question is what will the share price do tomorrow?

Let’s all hope the upward trend continues

Thanks

Unfortunately it was over 50% rise earlier. The big question is where will it finish tonight. It was up nearly 20% yesterday and ended up in the red

Thanks

All gone quiet, will we get a late afternoon rush to finally take us back up the nominal 1p.

Thanks

Just a name change

Thanks

Thanks Phil

Max don’t jinx it

We haven’t had this much excitement for ages

Thanks

Hopefully this isn’t one of the days we are used to where a good RNS leads to a big rise then the profit taking at the end of the days leaves us below the starting price. Fingers crossed that doesn’t happen and it is just the start.

Good luck everyone

Thanks

We can’t sell our own stuff so let’s try selling someone else’s.

I think we have got this agreement is it helps the company expand into Alzheimer’s and MS.

Not the RNS we hope or expected. Let’s see what the next one brings.

Thanks

Paladin

I would say the thing against it being a lifestyle company is the reputation of the medical staff at MCW and AM’s reputation. Why would they want to be associated with anything that could harm their years worth of research.

The issue I would say is we are too small. We need somebody to invest far more money than TB ever has. The development would increase exponentially then in my opinion.

Thanks

Thanks Mallettp

I believe we have had some data released before and now just need the “final” data from all the participants but as you say the average survival time can change as the participants keep going. Hopefully that time will keep increasing and help more sufferers.

Thanks

Does anybody know the possible process and time scale for analysing and writing up the phase 1 results?

Would it be something like:

Draft, peer review, given to FDA, published?

We could be several months with no updates.

Thanks

Not what we know about. They said waiting for phase 1 data before resubmitting. The question is when will we get the results from phase 1. That will be make or break for the company if they can’t sell any imaging products.

Thanks

Unfortunately Showjumper our only way of advertising our world leading products it now seems is via word of mouth at conferences like this.

Thanks

Thanks Max

I assume we are at this event.

https://www.asfnr.org/program

It mentions prism but I can’t se IB anywhere. If we are trying to change tactics to sell our imaging products we should be banging on the door to do a presentation or workshop.

Thanks (this is where Max says IB have already tweeted about it)

Showjumper when we don’t hear from semantic it could be a closed period for some big announcement we don’t know about yet. That’s what we always hope anyway.

So if we hear from semantic then no news is imminent.

Thanks

Max

The website seems to have taken a back seat. At a guess all focus is on writing up phase 1 as they know how important that is. Or somebody may want to buy us (which we don’t know about yet) hence why update the website if it was soon to be redundant.

Hopefully the next RNS is of the kind we have all been waiting though, fingers crossed.

Thanks

Have a good weekend everybody. Hopefully some good news soon.

Thanks

So exclusitivity for those years. Which is the same as having a patent I believe.

Plus new patent application

Thanks